UniProt ID | MCM2_MOUSE | |
---|---|---|
UniProt AC | P97310 | |
Protein Name | DNA replication licensing factor MCM2 | |
Gene Name | Mcm2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 904 | |
Subcellular Localization | Nucleus . | |
Protein Description | Acts as component of the MCM2-7 complex (MCM complex) which is the putative replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. Required for the entry in S phase and for cell division. Plays a role in terminally differentiated hair cells development of the cochlea and induces cells apoptosis.. | |
Protein Sequence | MAESSESLSASSPARQRRRISDPLTSSPGRSSRRADALTSSPGRDLPPFEDESEGLLGTEGPMEEEEDGEELIGDGMERDYRPIPELDVYEAEGLALDDEDVEELTASQREAAERTMRQRDREAGRGLGRMRRGLLYDSSEEDEERPARKRRHVERATEDGEEDEEMIESIENLEDLKGHSVREWVSMAGPRLEIHHRFKNFLRTHVDSHGHNVFKERISDMCKENRESLVVNYEDLAAREHVLAYFLPEAPAELLQIFDEAALEVVLAMYPKYDRITNHIHVRISHLPLVEELRSLRQLHLNQLIRTSGVVTSCTGVLPQLSMVKYNCSKCNFVLGPFCQSQNQEVKPGSCPECQSAGPFEINMEETIYQNYQRIRIQESPGKVAAGRLPRSKDAILLADLVDSCKPGDEIELTGIYHNNYDGSLNTANGFPVFATIILANHVAKKDNKVAVGELTDEDVKMITGLSKDQQIGEKIFASIAPSIYGHEDIKRGLALALFGGEPKNPGGKHKVRGDINVLLCGDPGTAKSQFLKYIEKVSSRAIFTTGQGASAVGLTAYVQRHPVSREWTLEAGALVLADRGVCLIDEFDKMNDQDRTSIHEAMEQQSISISKAGIVTSLQARCTVIAAANPIGGRYDPSLTFSENVDLTEPIISRFDVLCVVRDTVDPVQDEMLARFVVGSHVRHHPSNKKDEGLTNGGTLEPAMPNTYGVEPLPQEVLKKYIIYAKERVRPKLNQMDQDKVARMYSDLRKESMATGSIPITVRHIESMIRMAEAHARMHLRDYVMEDDVNMAIRVMMESFIDTQKFSVMRSMRKTFARYLSFRRDNNDLLLFILKQLVAEQVTYQRNRFGAQQDTIEIPEKDLMDKARQINIHNLSAFYDSDLFKFNKFSRDLKRKLILQQF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAESSESLS ------CCCCCCCCC | 25.94 | 19131326 | |
4 | Phosphorylation | ----MAESSESLSAS ----CCCCCCCCCCC | 29.84 | 27566939 | |
5 | Phosphorylation | ---MAESSESLSASS ---CCCCCCCCCCCC | 23.78 | 27566939 | |
7 | Phosphorylation | -MAESSESLSASSPA -CCCCCCCCCCCCHH | 29.58 | 25168779 | |
9 | Phosphorylation | AESSESLSASSPARQ CCCCCCCCCCCHHHH | 35.07 | 27566939 | |
11 | Phosphorylation | SSESLSASSPARQRR CCCCCCCCCHHHHHH | 33.22 | 23527152 | |
12 | Phosphorylation | SESLSASSPARQRRR CCCCCCCCHHHHHHC | 23.46 | 23527152 | |
21 | Phosphorylation | ARQRRRISDPLTSSP HHHHHCCCCCCCCCC | 31.22 | 27087446 | |
25 | Phosphorylation | RRISDPLTSSPGRSS HCCCCCCCCCCCCHH | 32.33 | 27087446 | |
26 | Phosphorylation | RISDPLTSSPGRSSR CCCCCCCCCCCCHHH | 42.07 | 27087446 | |
27 | Phosphorylation | ISDPLTSSPGRSSRR CCCCCCCCCCCHHHH | 26.58 | 27087446 | |
31 | Phosphorylation | LTSSPGRSSRRADAL CCCCCCCHHHHHHHC | 33.83 | 22942356 | |
32 | Phosphorylation | TSSPGRSSRRADALT CCCCCCHHHHHHHCC | 25.15 | 27600695 | |
39 | Phosphorylation | SRRADALTSSPGRDL HHHHHHCCCCCCCCC | 28.95 | 22942356 | |
40 | Phosphorylation | RRADALTSSPGRDLP HHHHHCCCCCCCCCC | 35.07 | 26824392 | |
41 | Phosphorylation | RADALTSSPGRDLPP HHHHCCCCCCCCCCC | 26.58 | 27087446 | |
53 | Phosphorylation | LPPFEDESEGLLGTE CCCCCCCCCCCCCCC | 49.65 | 21149613 | |
59 | Phosphorylation | ESEGLLGTEGPMEEE CCCCCCCCCCCCCCC | 37.42 | 21149613 | |
90 | Phosphorylation | PIPELDVYEAEGLAL CCCCCCEEEECCCCC | 14.75 | 30635358 | |
106 | Phosphorylation | DEDVEELTASQREAA HHHHHHHHHHHHHHH | 27.78 | 26239621 | |
108 | Phosphorylation | DVEELTASQREAAER HHHHHHHHHHHHHHH | 25.24 | 27087446 | |
108 | O-linked_Glycosylation | DVEELTASQREAAER HHHHHHHHHHHHHHH | 25.24 | 29562282 | |
137 | Phosphorylation | RMRRGLLYDSSEEDE HHHCCCCCCCCHHHC | 20.87 | 27149854 | |
139 | Phosphorylation | RRGLLYDSSEEDEER HCCCCCCCCHHHCCC | 26.54 | 27087446 | |
140 | Phosphorylation | RGLLYDSSEEDEERP CCCCCCCCHHHCCCC | 41.95 | 27087446 | |
158 | Phosphorylation | RRHVERATEDGEEDE HHHHHHHCCCCCHHH | 40.61 | 25619855 | |
170 | Phosphorylation | EDEEMIESIENLEDL HHHHHHHHHHCHHHH | 25.03 | 25619855 | |
209 | Phosphorylation | FLRTHVDSHGHNVFK HHHHHHHHCCCHHHH | 30.22 | 27841257 | |
216 | Acetylation | SHGHNVFKERISDMC HCCCHHHHHHHHHHH | 41.63 | - | |
229 | Phosphorylation | MCKENRESLVVNYED HHHHCHHHEECCHHH | 24.19 | 22817900 | |
308 | Phosphorylation | HLNQLIRTSGVVTSC HHHHHHHHHCCCCCC | 23.88 | 30635358 | |
309 | Phosphorylation | LNQLIRTSGVVTSCT HHHHHHHHCCCCCCC | 21.53 | 30635358 | |
313 | Phosphorylation | IRTSGVVTSCTGVLP HHHHCCCCCCCCCHH | 18.71 | 30635358 | |
314 | Phosphorylation | RTSGVVTSCTGVLPQ HHHCCCCCCCCCHHH | 9.70 | 30635358 | |
316 | Phosphorylation | SGVVTSCTGVLPQLS HCCCCCCCCCHHHHH | 30.05 | 30635358 | |
323 | Phosphorylation | TGVLPQLSMVKYNCS CCCHHHHHCEEECCC | 19.11 | 30635358 | |
327 | Phosphorylation | PQLSMVKYNCSKCNF HHHHCEEECCCCCCE | 15.25 | 30635358 | |
330 | Phosphorylation | SMVKYNCSKCNFVLG HCEEECCCCCCEEEC | 36.28 | 30635358 | |
381 | Phosphorylation | QRIRIQESPGKVAAG HEEEEECCCCCCCCC | 23.68 | 27600695 | |
457 | Phosphorylation | KVAVGELTDEDVKMI CEEEEECCHHHHHHH | 32.80 | 26525534 | |
462 | Acetylation | ELTDEDVKMITGLSK ECCHHHHHHHHCCCC | 36.59 | 23236377 | |
480 | Phosphorylation | IGEKIFASIAPSIYG HHHHHHHHHCHHHHC | 14.45 | 26239621 | |
484 | Phosphorylation | IFASIAPSIYGHEDI HHHHHCHHHHCCHHH | 21.30 | 26239621 | |
534 | Acetylation | TAKSQFLKYIEKVSS CHHHHHHHHHHHHCC | 45.53 | 22826441 | |
538 | Acetylation | QFLKYIEKVSSRAIF HHHHHHHHHCCCEEE | 37.55 | 22826441 | |
546 | Phosphorylation | VSSRAIFTTGQGASA HCCCEEEECCCCCCC | 24.73 | 20531401 | |
547 | Phosphorylation | SSRAIFTTGQGASAV CCCEEEECCCCCCCE | 19.43 | 20531401 | |
552 | Phosphorylation | FTTGQGASAVGLTAY EECCCCCCCEECEEH | 30.25 | 20531401 | |
591 | Acetylation | CLIDEFDKMNDQDRT EEECCHHHCCCCCCH | 44.94 | 22826441 | |
599 | Phosphorylation | MNDQDRTSIHEAMEQ CCCCCCHHHHHHHHH | 23.88 | 25338131 | |
757 | Phosphorylation | LRKESMATGSIPITV HHHHHHHCCCCCEEH | 23.87 | 29895711 | |
759 | Phosphorylation | KESMATGSIPITVRH HHHHHCCCCCEEHHH | 22.34 | 29895711 | |
763 | Phosphorylation | ATGSIPITVRHIESM HCCCCCEEHHHHHHH | 13.21 | 29895711 | |
857 | Phosphorylation | RFGAQQDTIEIPEKD CCCCCCCCEECCHHH | 19.03 | 29514104 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
40 | S | Phosphorylation |
| - |
53 | S | Phosphorylation |
| - |
108 | S | Phosphorylation |
| 21183079 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MCM2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MCM10_HUMAN | MCM10 | physical | 11095689 | |
TIM_MOUSE | Timeless | physical | 17141802 | |
MCM3_HUMAN | MCM3 | physical | 26496610 | |
MCM4_HUMAN | MCM4 | physical | 26496610 | |
MCM5_HUMAN | MCM5 | physical | 26496610 | |
MCM6_HUMAN | MCM6 | physical | 26496610 | |
MCM7_HUMAN | MCM7 | physical | 26496610 | |
ECD_HUMAN | ECD | physical | 26496610 | |
HSPB8_HUMAN | HSPB8 | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-21; SER-27;SER-139 AND SER-140, AND MASS SPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21, AND MASSSPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-27; SER-41;SER-139 AND SER-140, AND MASS SPECTROMETRY. | |
"A differential phosphoproteomic analysis of retinoic acid-treated P19cells."; Smith J.C., Duchesne M.A., Tozzi P., Ethier M., Figeys D.; J. Proteome Res. 6:3174-3186(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; THR-25; SER-27;SER-139 AND SER-140, AND MASS SPECTROMETRY. | |
"Phosphoproteomic analysis of the developing mouse brain."; Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.; Mol. Cell. Proteomics 3:1093-1101(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-139 AND SER-140,AND MASS SPECTROMETRY. | |
"Identification of phosphoproteins and their phosphorylation sites inthe WEHI-231 B lymphoma cell line."; Shu H., Chen S., Bi Q., Mumby M., Brekken D.L.; Mol. Cell. Proteomics 3:279-286(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-26 AND SER-27,AND MASS SPECTROMETRY. |